Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06262386
What this trial is testing

Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial

Who this might be right for
Lung CancerRelapse/Recurrence
Chang Gung Memorial Hospital 358
Testing effectiveness (Phase 2)Study completedNCT03081689
What this trial is testing

Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients

Who this might be right for
Non Small Cell Lung Cancer
Spanish Lung Cancer Group 46
Early research (Phase 1)Ended earlyNCT05088967
What this trial is testing

Efficacy and Safety of IBI110 in Combination With Sintilimab Versus Sintilimab Alone in Neoadjuvant and Adjuvant Therapy of Radically Resectable Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Innovent Biologics (Suzhou) Co. Ltd. 6
Testing effectiveness (Phase 2)Looking for participantsNCT06788912
What this trial is testing

Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)

Who this might be right for
Lung Neoplasm Malignant
Merck Sharp & Dohme LLC 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06682884
What this trial is testing

Lorlatinib as Neoadjuvant Treatment in Stage IB-IIIB ALK-rearranged Non-Small Cell Lung Cancer

Who this might be right for
Neoadjuvant Non-Small Cell Lung Cancer
Peking University People's Hospital 25
Large-scale testing (Phase 3)Active Not RecruitingNCT03425643
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 797
Testing effectiveness (Phase 2)Looking for participantsNCT06718309
What this trial is testing

Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
First People's Hospital of Hangzhou 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04245514
What this trial is testing

Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung CancerNSCLC
Swiss Cancer Institute 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07567326
What this trial is testing

Adebrelimab or Retlirafusp Alfa Plus Recaticimab and Chemotherapy for Resectable NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Peking University Cancer Hospital & Institute 78
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Looking for participantsNCT06312137
What this trial is testing

Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Who this might be right for
Non Small Cell Lung Cancer
Merck Sharp & Dohme LLC 780
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07438600
What this trial is testing

Study of Sacituzumab Tirumotecan Combined With Toripalimab for Resectable Stage II-IIIB NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Tianjin Medical University Cancer Institute and Hospital 38
Early research (Phase 1)UnknownNCT05157542
What this trial is testing

Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC

Who this might be right for
Stage III Non-small Cell Lung Cancer
Juan LI, MD 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07704645
What this trial is testing

The Clinical Study of Adalimumab Combined With Other Anti-tumor Therapy as a Treatment for Resectable Non-small Cell Lung Cancer

Who this might be right for
Resectable Non-small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT05430802
What this trial is testing

Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIA-IIIB Resectable NSCLC (FORESEE)

Who this might be right for
Non-small Cell Lung Cancer
Tang-Du Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT04512430
What this trial is testing

Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients

Who this might be right for
Non Small Cell Lung CancerEGFR Gene Mutation
Fundación GECP 4
Testing effectiveness (Phase 2)Study completedNCT03088930
What this trial is testing

Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer, Nonsmall Cell
University of Colorado, Denver 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07493980
What this trial is testing

Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients

Who this might be right for
NSCLC Stage II
Shanghai Pulmonary Hospital, Shanghai, China 54
Not applicableLooking for participantsNCT07652736
What this trial is testing

Investigate Treatment Patterns and Effectiveness of Tislelizumab in European Patients With Resectable or Advanced Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)

Who this might be right for
Advanced Non-Small Cell Lung CancerExtensive-Stage Small Cell Lung Cancer
BeOne Medicines 440
Not applicableStudy completedNCT00960271
What this trial is testing

Evaluation of Preoperative Endobronchial Ultrasound (EBUS) in Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
University Hospital, Rouen 363
Next Page